In contrast to these protective effects, SARS‐CoV‐2, the virus that causes COVID‐19, uses ACE2 to enter target cells,15 which led to the hypothesis that ACEIs/ARBs could modulate COVID‐19 disease outcomes. Here, ACE2 is linked to COVID-19.